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Research Chair to SF. The content is solely the responsibility of the authors and does not necessarily 27 represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health 28 care centers, the National Institutes of Health or the Sidney R. Baer Jr. Foundation. 29 It has been shown in multiple works that craving can be induced by environmental cues alone, 114
independently from the state of abstinence (Franklin et al., 2007) . Successful abstinence is consistently 115 associated with the capacity to resist craving. Therefore, reduction of craving and/or ability to resist 116 craving, may thus represent critical objectives and major therapeutical outcomes across SUDs (see 117 Figure 1 ). A balance between reflective (i.e decision-making, executive) and reflexive (i.e reward-118 biased, impulsive) systems is thought to regulate drug-related behavior, and more generally, reward-119 associated behavior and response to craving (Bechara et al., 2005) . The reflective system exerts top-120 down control on the impulsive system, thus regulating emotions and affective states. However, 121 decision-making is a complex process that requires integration of information and can thus be 122 influenced by the reflexive system. Chronic drug consumption would facilitate a hyperactivity and 123 hypersensitivity of the reflexive system, overcoming the reflective system. This neurocognitive model 124 is strongly based on neuroanatomical organization of the reward system, with a limbic drive circuit 125 comprising projections from the medial prefrontal cortex to the nucleus accumbens (the reflexive 126 system), and an executive control circuit comprising projections from the DLPFC to the dorsal part of 127 the striatum (the reflective system) (Hanlon et al., 2015).
129
Page 4 of 28 A c c e p t e d M a n u s c r i p t Nicotine inhaled from cigarette smoke is carried from the lungs to the brain where it selectively binds 158 to nicotinic cholinergic receptors (nAChRs). Direct stimulation of these receptors activates the 159 liberation of dopamine in the mesocorticolimbic pathways, among other neurotransmitters. Acute and 160 repeated chronic effects of nicotine result in the activation of the prefrontal cortex, visual areas and 161 thalamus. Nicotine intake increases dopamine concentration in the ventral tegmental area (VTA), 162 nucleus accumbens (NA) and striatum, which is thought to provide the pleasurable and arousing effects 163 of cigarette smoking. The stimulation of dopamine pathways also allows the liberation of GABA and 164 glutamate, neurotransmitters that respectively have inhibiting and facilitating effects on dopamine 165 transmission. Chronic use of nicotine tones down the inhibitory action of GABA release but maintains 166 the release of glutamate, which facilitates the release of dopamine and enhances the reinforcing effects 167 of nicotine. Other hypotheses of the development of nicotine SUD point at the reduction of the activity 168 of monoamine oxidase A and B (MAO-A and MAO-B), both enzymes involved in the catalysis of 169 catecholamines (Schwartz and Benowitz, 2010) . Importantly, nicotine also stimulates the release of 170 acetylcholine, serotonin, norepinephrine and endorphins, triggering a global neurophysiological 171 response which may induce alterations in neuronal activity and excitability (Markou, 2008 holding a cigarette and a lighter. There was also a neutral cue condition, which consisted of 205 presentation of neutral pictures and holding a pencil and rubber eraser. They delivered low frequency 206
(1 Hz; 90% RMT) and high frequency bilateral rTMS (10 Hz; 90% RMT) over the superior frontal 207 gyrus (SFG). All participants received both types of stimulation and an active control condition with 208 stimulation (1 Hz; 90% RMT) to the motor cortex. High frequency rTMS to the SFG induced craving 209 during the smoking cue condition, whereas low frequency rTMS had no significant effect. In an 210 additional condition, they combined stimulation with controlled inhalation of actual cigarette smoke, by 211 means of a controlled cigarette puff volume apparatus. Prior to stimulation, subjects inhaled a cigarette 212 with the apparatus to determine the volume of smoke normally inhaled with each puff. During 213 stimulation, subjects inhaled this volume of cigarette smoke. In this condition, active high frequency 214 rTMS decreased craving ratings (Rose et al., 2011 A c c e p t e d M a n u s c r i p t 6 underlying nicotine-craving reduction. They used high frequency rTMS (10Hz; 90%MT) applied to the 228 left DLPFC in smokers who were required to remain abstinent for 6 hours before stimulation. They 229 also recorded EEG delta brain waves before and after stimulation, which are presumably associated to 230 activity in the dopamine pathways and thought to be a neurobiological correlate of craving. They found 231 that both craving ratings and EEG delta power were reduced after active stimulation as compared to 232
sham (Pripfl et al., 2013 of tES on the number of cigarettes smoked on the following day and attention bias to smoking-related 291 cues using an eye-tracking system. There were 3 stimulation conditions (20 min, 1 mA): cathodal 292 stimulation over the frontal-parietal-temporal area (FPT) of both hemispheres with anodal stimulation 293 over both occipital cortices; cathodal stimulation over the right FPT and anodal stimulation over the 294 right occipital cortex; and sham tES. Main findings were a decrease of cigarette consumption in 295 subjects who received bilateral cathodal tES over the FPT and an attentional shift from smoking-related 296 to neutral cues as compared to the other groups (Meng et al., 2014) . In summary, these results provide 297
interesting support for the clinical potential of tES in TUD (see Table 1 ).
299
Over a total of four studies assessing the use of tES on tobacco-related craving, all delivering 2 mA, 300 two have reported a decrease in craving, one reported a decrease in craving in one subscale over a total 301 of four, and one study found no changes in craving (see Table 1 ). The three studies reporting a decrease 302 in craving targeted both DLPFCs whereas the study reporting no changes applied anodal stimulation to 303 the left DLPFC and cathodal over the right supraorbital area. In regards to subjects, three of the studies 304 reporting decreases in craving did not require subjects to be abstinent, whereas subjects were abstinent 305 for a minimum of ten hours in the other study. Only one study recruited treatment-seekers and all four 306 studies used a cue-provoked paradigm. 307 308
Please insert Table 1 In regards to stimulation parameters, one study used 10Hz over the right DLPFC and the other 1 Hz 386 over the dorsal ACC. The three unsuccessful studies all used 20 Hz, one over the left DLPFC and two 387 over the right DLPFC. All studies required their subjects to be abstinent, as most of them were 388 treatment-seeking in-clinic patients. One of the two studies reporting a decrease in craving used a cue-389 provoked paradigm and the other did not. The three studies reporting no changes in craving did not use 390 a cue-provoked paradigm to assess the effect of rTMS on craving. In regards to craving assessments, 391 one study used the ACQ-NOW with 5 factors and one used a single item VAS. The other studies used 392 the OCDS (see Table 2 ). 
abstinent across the studies, except for the den Uyl study, which included hazardous drinkers among a 425 student population. In regards to craving measurements, between the three successful studies, one used 426 the AUQ, one the OCDS and one the AAAQ. All studies used a cue-provoked paradigm, except for the 427 den Uyl study which only measured baseline craving before and after tDCS. The study from 428 Nakamura-Palacios and colleagues (2012), which reported no changes, used the OCDS to assess 429 alcohol craving but did not use a cue-provoked paradigm (see Table 2 ). 430 431
Please insert Table 2 (Li et al., 2013b) . The authors propose that inhibitory action of low frequency 503 rTMS over the prefrontal cortex may allow increased activity of the craving-related subcortical regions.
504
Two of the four experiments described demonstrate that rTMS has potential in the reduction of 505 psychostimulant craving, with several subsequent sessions providing a stronger effect (see Table 3 ). 506
However, it remains evident that more thorough research has to be conducted, taking into account the 507 type of patient and the optimal stimulation parameters, namely the stimulation target as discussed in 508 (Fecteau et al., 2010).
510
The two studies reporting a decrease in craving used high frequency rTMS; one targeted the left 511 DLPFC and the other the right DLPFC. The study reporting no change used high frequency rTMS over 512 the left DLPFC and the study reporting an increase in craving delivered 1Hz rTMS over the left 513 DLPFC. In regards to subjects, they were abstinent in all studies. In regards to outcome measures, the 514 two conditions showing a decrease in craving and the one showing no change did not use a cue-515 provoked paradigm, whereas the study demonstrating an increase in craving used a cue-provoked 516 paradigm (see Table 3 ). 517 518
Please insert Table 3 about here  519  520 Transcranial electric stimulation in psychostimulant use disorders 521
Page 12 of 28 A c c e p t e d M a n u s c r i p t 12 One study has assessed the effect of tES on cocaine-related cue reactivity (Conti et al., 2014) . In this 522 work, they measured event-related potentials cue-reactivity in abstinent crack-cocaine users. They 523 measured craving before and after the first tES session, and after the fifth and final tES sessions. They 524 found that a single session of anodal tES (2 mA, 20min) over the right DLPFC coupled with cathodal 525 tES over the left DLPFC did not decrease craving compared to sham tES (see Table 3 ). Moreover, 526
there was no effect after 5 sessions of active tES compared to sham. There was no significant effect on 527 cocaine intake at 3-months follow-up, but found that 5 subjects in the active tES group and one for the 528 sham group had remained abstinent (Conti and Nakamura-Palacios, 2014).
530
One study has investigated the effect of tES in abstinent male METH-dependent subjects (Shahbabaie 531 et al., 2014) . This was a randomized, sham-controlled, double-blind, cross-over design and subjects 532 received one active and one sham stimulation session, with the anode over the right DLPFC and the 533 cathode over the left supraorbital area at 2 mA 20 min with a wash-out period of 72 hours. Craving 534 levels were measured before, during and after each tES session on a 1-item VAS, and were asked to 535 rate their METH craving spontaneously. There was an effect of time (pre, during, post) and stimulation 536 (sham, active) but interaction did not reach significance. 537 538
Over two studies using tES for psychostimulant craving, one demonstrated a decrease in craving and 539 the other did not. They used the same stimulation parameters (20min, 2mA). The one reporting a 540 decrease in craving applied anodal to the right DLPFC and cathodal to the left supraorbital area 541 (Shahbabaie et al., 2014) whereas the one that did not applied anodal stimulation over the right DLPFC 542 and cathodal over the left DLPFC (Conti et al., 2014) . In regards to patients, the study reporting a 543 decrease in craving used 1-week abstinent subjects whereas the other study required a minimum of 31-544 days of abstinence. Both studies used a cue-provoked paradigm (see Table 3 ). 545 546 547
General discussion 548 549
Studies presented in this review provide insight for the use of NIBS in reducing craving and 550 consumption of addictive substances. A recent meta-analysis has explored the effects of rTMS and tES 551 on craving reduction for diverse substances and provided statistical evidence that these techniques can 552 decrease craving levels for food, nicotine, alcohol and marijuana (Jansen et al., 2013). They found an 553 effect size of 0.476, which encourages future investigations. Of interest, there was no significant 554 difference between rTMS and tES in decreasing craving. Moreover, the magnitude of the effects was 555 not different across substances. The authors also tested whether targeting the left or right DLPFC with 556 NIBS induced greater benefits on craving. Although there was no significant statistical difference, 557 greater craving suppression was reported when targeting the right hemisphere. 558 559
Although the results described in this review mainly come from experimental studies, it is worth 560 comparing NIBS with traditional pharmacology and behavioral interventions. A c c e p t e d M a n u s c r i p t 13 retain patients in treatment and does not reduce the high mortality rate of patients (Mattick et al., 2009 described that stress plays a major role in major depression, through hyper reactivity to stressors, and 592
SUDs, through reinstatement of craving. It has been suggests that some beneficial effects of NIBS in 593 such psychopathologies (major depression and SUDs) may share a common pathway (Brunelin & 594
Fecteau, 2014). There is still however a crucial need for the development of a biophysical model of 595 rTMS and tES to decipher their potentially numerous mechanisms of action of clinical effects. 596
We have discussed several theoretical and technical issues related to the potential use of NIBS in 597
SUDs. It is also worth addressing the potential side effects of such devices. Most common side effects 598 of rTMS are headaches, neck pain and transient hearing changes (Rossi et al., 2009). For tES, side 599 effects reported in the general literature seem similar that the ones reported in studies including patients 600 with SUDs stated in this article. They include headaches, mild tingling, dizziness and increased skin 601 sensibility at the location of electrodes. However, no studies reported disruption of the protocol or 602 resignation of subjects due to side effects. In the context of eventually using NIBS in the treatment of 603 SUDs, it is also important to think of possible side effects. If stimulation of the prefrontal cortex does 604 entail an excitatory effect over cortical and subcortical structures, as suggested by several authors, and 605 promotes the indirect stimulation of the dopamine pathways (Cho & Strafella, 2009 ), one may propose 606 that NIBS would develop "addictive properties" if administered chronically. Similarly to 607 pharmacological replacement therapy (e.g., nicotine replacement therapy) or cross-sensitization studies 608 (i.e., when a substance is replaced with another substance), NIBS could technically create a shift in 609
SUDs. We propose that this "side effect" would in fact be beneficial as it would, given ideal NIBS 610 parameters and continuous professional counseling, reduce cravings through stimulation of the 611 dopamine pathways, limit the advent of withdrawal symptoms and gradually deplete 612 neuropsychological vulnerability to environmental substance cues and stress associated with substance 613 craving. However, this hypothesis relies on a simplistic explanation of NIBS mechanisms of action; 614 actual mechanisms of action may be far more complex and likely recruit cerebral structures other than 615 the prefrontal cortex and striatum, thus recruiting supplementary neurotransmitter systems other than 616 glutamate and dopamine. 617 618
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Although experimental results are promising, the mechanisms of action of NIBS underlying its 619 potential in reducing craving and substance use have yet to be characterized and several questions 620 remain unanswered. Here we delimitate four general categories of factors that can mediate the effects 621 rTMS or tES on craving: 1) stimulation parameters, 2) subjects' brain state, 3), experimental measures 622 of craving and 4) the sample characteristics. 623 624
1) The effects of stimulation parameters on craving 625
Stimulation parameters vary across reported studies, and this has to be taken into account for several 626 reasons. First, mechanisms underlying the effects of rTMS and tES remain elusive, even in the healthy 627 resting brain. The possibility for these two techniques of not sharing the same neurophysiological 628
effects cannot be put aside, especially across SUDs. As mentioned in the introduction, rTMS and tES 629 likely have different neurophysiological effects. Specificity of future studies and combination with 630 neuroimaging modalities (e.g., Hone-Blanchet et al., 2015; Bestmann & Feredoes, 2013) will likely 631 help elucidate these differences. 632 633
In addition to this difference between the rTMS and tES devices, the choice of the brain target, the 634 nature of stimulation (presumably known to be excitatory or inhibitory), duration and intensity, all 635 critical aspects in conducting a clinically relevant stimulation protocol, vary highly across studies in 636 SUDs.
638
Most studies have targeted the DLPFC with rTMS or tES to diminish craving and substance intake in 639
SUDs. Although a complex network is involved in craving in SUDs, the DLPFC may be one of the 640 only cortical locations targetable by NIBS to impact the dopamine pathways and the insula (Garavan, have proposed that the reduction in craving following stimulation may be mediated by the frontolimbic 648 connections of the DLPFC with structures of the basal ganglia. Moreover, connections from the OFC to 649 the striatum and amygdala, regulating motivational behavior and reward, may also be involved in the 650 observed effect. The DLPFC is also a crucial relay in decision-making processes, and is thought to be 651 essential in the behavioral regulation of craving throughout the prefrontal-striatal pathways (Kober and  652 Mende-Siedlecki, 2010). In brief, among a complex network that has been associated with SUDs, the 653 DLPFC seems to be the best candidate to be non-invasively targeted with NIBS to reduce craving 654 across SUDs. We propose that excitatory stimulation of the DLPFC may act on GABA and glutamate 655 transmission and thus indirectly facilitate dopamine release in the mesocortical pathway, thus 656 transiently reducing substance craving (see Figure 2) . The DLPFC has been largely targeted in the 657 studies mentioned in this article. Although this region remains of critical interest, because it is easily 658 targetable from the scalp and relevant in SUDs, other regions may be tested in future work. The insula 659
for instance is becoming a target of primary importance in SUDs. Located inside the lateral sulcus, it 660 receives inputs from the thalamus, parietal, occipital, temporal and frontal cortices. Moreover, it has 661 reciprocal connections with the amygdala and nucleus accumbens. It is activated during drug craving 662 and this activation is correlated with ratings of craving. Craving assessment design in itself is also important in determining the effect of NIBS in SUDs. The 784 multiple questionnaires used to assess craving in NIBS studies vary in quality, based on the number of 785 items and subscales and the level of standardization. For instance, some studies asked subjects to rate 786 their craving level by asking a single question (e.g., How much do you desire to smoke?). This is a 787 methodological choice that allows the measure of craving at the exact moment (if for instance tested 788 multiple times during a 10-min tES session), which would be difficult if using a longer, more detailed 789 questionnaire. However, one question does not fully capture the different aspects of craving, and from a 790 methodological standpoint likely limits the evaluation of the whole construct of craving and statistical 791 power. We, for instance, reported significant changes in craving only for one specific subscale among 792 the four subscales (Desire to smoke, Anticipation of positive outcome, Relief from negative affect, and 793
Intention to smoke) within the standardized Questionnaire of Smoking Urges from Tiffany and Drobes 794 (1991) (Fecteau et al., 2014) . It is thus possible that NIBS only modulates some specific aspects of 795 craving. Another methodological aspect that is essential to consider when discussing studies using 796 NIBS to reduce craving is how ratings of craving were reported. Studies have used either VAS or 797 categorical craving scores. As reported by several authors, categorical scores may not capture small 798 changes in craving that VAS may capture. 799 800
Finally, other methodological aspects important for any NIBS studies are also relevant when addressing 801
SUDs. For instance, control of sham condition and blinding levels are critical in an effort to assess the 802 clinical relevance of NIBS in SUDs and several studies have not reported how these were done.
803
Avoidance of carry over effects is also essential in this regard within repeated sessions paradigms, to 804
determine the effect of the tested stimulation design itself. In line with this, in crossover paradigms, 805 craving assessments need to be assessed before each arm to provide a secure baseline for experimental 806 measurements. In sum, we propose that identifying and inducing the ideal brain state to obtain the greatest craving 833 reduction with NIBS should be a priority in the amelioration of such alternatives. In the same 834 perspective, combination of NIBS with medication for smoking cessation also has to be considered. A c c e p t e d M a n u s c r i p t
